Back to Top Skip to main content Skip to sub-navigation

Specialized robots used to disinfect NH TwentyninePalms

Image of Hospital personnel standing with a cleaning robot. Teresa Turbyfill, hospital infection preventionist (left), poses with NHTP hospital corpsmen and a company representative, behind one of their new broad spectrum UV light robotic units. (Photo by David Marks, NHTP PAO.)

Recommended Content:

Public Health | Coronavirus & the MHS Response | Coronavirus and the COVID-19 Vaccine

Robots shooting high-energy pulses to kill germs is not the future. It is now.

Naval Hospital Twentynine Palms at the Marine Corps Air Ground Combat Center in southern California recently purchased two robotic units that pulse high energy, broad spectrum UV light, to disinfect surface areas.

Registered nurse Teresa Turbyfill, infection preventionist in the hospital's Quality Management Department, raised the idea of purchasing the robots as the COVID-19 pandemic continued to grow in the early spring.

"Ultraviolet radiation emitting robots have been around for 20 years," Turbyfill said. "With the need for greater infection control, we are now using them in our operating rooms, in our post-anesthesia care unit and on the maternity ward. They've been a great success."

The robotic units are designed to complement manual cleaning and have been validated to deactivate pathogens such as VRE, MRSA, C. diff and SARS CoV-2.

Curtiss Hargrove, the hospital's Environmental Services supervisor, noted that his staff is thrilled with the addition of the robotic disinfection units. "The robots have been a great addition to the command, making it a much safer place," Hargrove stated. "My staff enters restricted areas for cleaning and disinfecting and these robots make them feel safer. Not only has my workers' morale improved, but also the quality of their work."

You also may be interested in...

Consolidated Department of Defense Coronavirus Disease 2019 Force Health Protection Guidance

Policy

Consolidates and updates the Department’s guidance regarding vaccination verification, vaccination status, COVID-19 testing, surveillance and screening testing, personnel protection on-site mask requirements, (e.g., DHA military medical treatment facilities, meetings, travel), and the protection of personally identifiable information.

DHA-IPM 20-004: Department of Defense (DOD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

Establishes the Defense Health Agency’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the DHA’s implementation of the DOD’s COVID-19 Vaccination Program.

Coronavirus Disease 2019 Vaccination Attestation, Screening Testing, and Vaccination Verification

Policy

This memorandum provides guidance on the implementation of vaccination, attestation, and testing requirements in accordance with the References listed in Attachment 1 to reduce the transmission of the virus that causes COVID-19.

Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

Establishes the DHA's procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits for enduring COVID-19 support.

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

Supplemental Guidance for Providing DOD Coronavirus Disease 2019 Vaccines to DOD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DOD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components.

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

Establishes the DHA's plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic

Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

Policy

The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.

DODI 6200.03: Public Health Emergency Management within the Department of Defense

Policy

In accordance with DoD Directive (DoDD) 5124.02, this issuance: • Establishes policy, assigns responsibilities, and provides direction to ensure mission assurance and readiness for public health emergencies caused by all-hazards incidents. • Defines a public health emergency within the DoD to include the occurrence or imminent threat of an illness or health condition that poses a high probability of a significant number of deaths, serious or long-term disabilities, widespread exposure to an infectious or toxic agent, overwhelmed health care resources, or severe degradation of mission capabilities. • Provides DoD policy for management of public health emergencies, in accordance with DoD Instruction (DoDI) 6055.17, through integration with the DoD Emergency Management (EM) Program. • Outlines the public health emergency health powers, roles, and responsibilities of the military installation commander, including the authority for restriction of movement. • Details procedures for internal and external notifications of DoD-declared public health emergencies. • Clarifies the PHEM roles and responsibilities of the medical treatment facility (MTF) commander or director, the public health emergency officer (PHEO), and the medical emergency manager (MEM).

  • Identification #: N/A
  • Date: 11/25/2019
  • Type: Instructions
  • Topics: Public Health

DoD Instruction 6490.13: Comprehensive Policy on Traumatic Brain Injury-Related Neurocognitive Assessments by the Military Services

Policy

This instruction establishes policy, assigns responsibilities, and prescribes standard elements, pursuant to section 722 of Public Law 111-383, requiring the implementation of a comprehensive neurocognitive assessment policy in the Military Services.

Embedded Fragment Analyses

Policy

Clarification of the Requirement for Continuation of Semi-Annual Reporting of Results of Embedded Fragment Analyses

<< < 1 2 > >> 
Showing results 1 - 15 Page 1 of 2
Refine your search
Last Updated: September 01, 2021

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.